Trial shows Lilly rival’s weight-loss pill could deliver same results as shots as companies race to market
Ahead of decisions by the FDA, both Novo Nordisk and Eli Lilly are readying production for their weight-loss pills, having been unable to keep up with demand for their shots that exploded in popularity.